Ascent Pharmahealth

    Board & Management

Managing Director and Chief Executive Officer
Dennis Bastas,   B.E., MAICD
Appointed Managing Director and CEO on formation of the Company in December 2003, Dennis was the founding force behind the initial strategy and creation of the Company. He has extensive senior management experience in business development, retail services and supply chain management with companies including Coles Myer Limited, Mannesmann AG and Village Roadshow Limited.

Non-Executive Chairman
Warren J. Jenkins,   B.Sc.
Director since February 2007 and Chairman since September 2009, Mr Jenkins has over 30 years experience in the global pharmaceutical industry having held senior executive positions at Smith Kline and Eli Lilly before joining Serono, a global biotechnology leader with over 4,750 employees, to build its regional Asia-Pacific sales and marketing operations as Regional Vice President, Oceania and Japan. Most recently Mr. Jenkins held the position of Vice-President Sales and Marketing, Europe & International for Serono.

 
Non-Executive Director
Arun Kumar,   B.Com
Mr. Kumar was appointed to the Board on 31 July 2008 and brings to the business a rich experience and deep knowledge of the international pharmaceutical industry. Mr. Kumar will also serve on the Remuneration and Nomination Committee. Mr. Kumar is the Founder of Strides Arcolab Limited (a listed company on the Bombay Stock Exchange) and has been a director of Strides Arcolab since its inception in 1990.

 


Non-Executive Director
T.S. Rangan,   B.Com., MBA, MS, M.Phil. and Ph.D (India)
Mr Rangan was appointed to the Board on 16 November 2009. Mr Rangan joined Strides Arcolab in April 2008 as Group CFO. He has over twenty years of experience in leading NYSE listed companies such as Xerox India, Astra Zeneca and Dr. Reddy’s Laboratories Ltd. Mr. Rangan holds Master of Philosophy, Master of Science and Master of Business Administration. As part of his doctoral degree, he has carried out a research on Corporate Governance. He is a Government Nominee on the Central Council of the Institute of Cost and Works Accountants of India.

 

COMPANY SECRETARIES

 
Andrew Burgess, B.Com, ACA
Mr Burgess was appointed Company Secretary on 22 July 2009.  Mr Burgess also serves as an executive of the company in his role as Chief Financial Officer.  Prior to joining the company, Mr Burgess was Chief Financial Officer of SteriHealth Limited.

Stephen L. Blank,   B.Ec., LL.B., LL.M., Grad.Dip., CSP
Mr. Blank was appointed Company Secretary on 1 July 2008. Mr. Blank also serves as an executive of the Company in his role as General Manager, Strategy and Development. Prior to joining the Company, Mr. Blank spent ten years as a private practice corporate lawyer with Deacons and Gadens Lawyers in Australia.

 

© Copyright Ascent Pharmahealth